Actions of the Clostridium botulinum binary toxin on the structure and function of Y-1 adrenal cells

H. Zepeda, Robert Considine, H. L. Smith, J. R. Sherwin, I. Ohishi, L. L. Simpson

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The binary toxin produced by Clostridium botulinum, also known as type C2 toxin, was examined for its ability to alter the structure and function of Y-1 cells, a murine adrenocortical tumor line. The toxin produced time- and concentration-dependent changes in morphology, characterized by retraction of cell extensions and by rounding of the cell body. These changes were not accompanied by increases or decreases in tissue levels of c-AMP or c-GMP, although there was an increase in the release of total steroids. When cells were exposed to toxin for 24 hr there was no evidence of cell death or lysis. Total nucleic acid content and the rate of incorporation of 14C-leucine into protein were comparable in control cells and intoxicated cells. The toxin has been shown to possess mono(ADP-ribosyl)ating activity, and actin is the presumed substrate. When Y-1 cells were ruptured and then exposed to the toxin in the presence of 32P-NAD, actin was ADP-ribosylated. When cells were exposed to the toxin before being ruptured, there was a subsequent loss in the amount of actin that was available for ADP-ribosylation (32P-NAD) in the broken cell assay. The data suggest that Y-1 cells can survive challenge with the botulinum binary toxin, and thus they are a suitable tissue in which to use the toxin as a pharmacological tool.

Original languageEnglish (US)
Pages (from-to)1183-1189
Number of pages7
JournalJournal of Pharmacology and Experimental Therapeutics
Volume246
Issue number3
StatePublished - 1988
Externally publishedYes

Fingerprint

Botulinum Toxins
NAD
Adenosine Diphosphate
Actins
Adenosine Monophosphate
Leucine
Nucleic Acids
Cell Death
Steroids
Pharmacology

ASJC Scopus subject areas

  • Pharmacology

Cite this

Actions of the Clostridium botulinum binary toxin on the structure and function of Y-1 adrenal cells. / Zepeda, H.; Considine, Robert; Smith, H. L.; Sherwin, J. R.; Ohishi, I.; Simpson, L. L.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 246, No. 3, 1988, p. 1183-1189.

Research output: Contribution to journalArticle

Zepeda, H. ; Considine, Robert ; Smith, H. L. ; Sherwin, J. R. ; Ohishi, I. ; Simpson, L. L. / Actions of the Clostridium botulinum binary toxin on the structure and function of Y-1 adrenal cells. In: Journal of Pharmacology and Experimental Therapeutics. 1988 ; Vol. 246, No. 3. pp. 1183-1189.
@article{037d87933685474a84fb540ea9f47e0a,
title = "Actions of the Clostridium botulinum binary toxin on the structure and function of Y-1 adrenal cells",
abstract = "The binary toxin produced by Clostridium botulinum, also known as type C2 toxin, was examined for its ability to alter the structure and function of Y-1 cells, a murine adrenocortical tumor line. The toxin produced time- and concentration-dependent changes in morphology, characterized by retraction of cell extensions and by rounding of the cell body. These changes were not accompanied by increases or decreases in tissue levels of c-AMP or c-GMP, although there was an increase in the release of total steroids. When cells were exposed to toxin for 24 hr there was no evidence of cell death or lysis. Total nucleic acid content and the rate of incorporation of 14C-leucine into protein were comparable in control cells and intoxicated cells. The toxin has been shown to possess mono(ADP-ribosyl)ating activity, and actin is the presumed substrate. When Y-1 cells were ruptured and then exposed to the toxin in the presence of 32P-NAD, actin was ADP-ribosylated. When cells were exposed to the toxin before being ruptured, there was a subsequent loss in the amount of actin that was available for ADP-ribosylation (32P-NAD) in the broken cell assay. The data suggest that Y-1 cells can survive challenge with the botulinum binary toxin, and thus they are a suitable tissue in which to use the toxin as a pharmacological tool.",
author = "H. Zepeda and Robert Considine and Smith, {H. L.} and Sherwin, {J. R.} and I. Ohishi and Simpson, {L. L.}",
year = "1988",
language = "English (US)",
volume = "246",
pages = "1183--1189",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Actions of the Clostridium botulinum binary toxin on the structure and function of Y-1 adrenal cells

AU - Zepeda, H.

AU - Considine, Robert

AU - Smith, H. L.

AU - Sherwin, J. R.

AU - Ohishi, I.

AU - Simpson, L. L.

PY - 1988

Y1 - 1988

N2 - The binary toxin produced by Clostridium botulinum, also known as type C2 toxin, was examined for its ability to alter the structure and function of Y-1 cells, a murine adrenocortical tumor line. The toxin produced time- and concentration-dependent changes in morphology, characterized by retraction of cell extensions and by rounding of the cell body. These changes were not accompanied by increases or decreases in tissue levels of c-AMP or c-GMP, although there was an increase in the release of total steroids. When cells were exposed to toxin for 24 hr there was no evidence of cell death or lysis. Total nucleic acid content and the rate of incorporation of 14C-leucine into protein were comparable in control cells and intoxicated cells. The toxin has been shown to possess mono(ADP-ribosyl)ating activity, and actin is the presumed substrate. When Y-1 cells were ruptured and then exposed to the toxin in the presence of 32P-NAD, actin was ADP-ribosylated. When cells were exposed to the toxin before being ruptured, there was a subsequent loss in the amount of actin that was available for ADP-ribosylation (32P-NAD) in the broken cell assay. The data suggest that Y-1 cells can survive challenge with the botulinum binary toxin, and thus they are a suitable tissue in which to use the toxin as a pharmacological tool.

AB - The binary toxin produced by Clostridium botulinum, also known as type C2 toxin, was examined for its ability to alter the structure and function of Y-1 cells, a murine adrenocortical tumor line. The toxin produced time- and concentration-dependent changes in morphology, characterized by retraction of cell extensions and by rounding of the cell body. These changes were not accompanied by increases or decreases in tissue levels of c-AMP or c-GMP, although there was an increase in the release of total steroids. When cells were exposed to toxin for 24 hr there was no evidence of cell death or lysis. Total nucleic acid content and the rate of incorporation of 14C-leucine into protein were comparable in control cells and intoxicated cells. The toxin has been shown to possess mono(ADP-ribosyl)ating activity, and actin is the presumed substrate. When Y-1 cells were ruptured and then exposed to the toxin in the presence of 32P-NAD, actin was ADP-ribosylated. When cells were exposed to the toxin before being ruptured, there was a subsequent loss in the amount of actin that was available for ADP-ribosylation (32P-NAD) in the broken cell assay. The data suggest that Y-1 cells can survive challenge with the botulinum binary toxin, and thus they are a suitable tissue in which to use the toxin as a pharmacological tool.

UR - http://www.scopus.com/inward/record.url?scp=0023742915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023742915&partnerID=8YFLogxK

M3 - Article

VL - 246

SP - 1183

EP - 1189

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 3

ER -